In an era where health is wealth, and the global healthcare sector is booming like never before, savvy investors are looking for opportunities that promise growth and a meaningful impact on people’s lives. Enter Novartis AG—a powerhouse in pharmaceuticals that’s not only redefining treatments but also setting new standards in innovation and sustainability.
A strong monthly demand imbalance at $97.13 per share has recently taken control. Expecting a decent reaction from this price level in the following weeks.
A strong monthly demand imbalance at $97.13 per share has recently taken control. Expecting a decent reaction from this price level in the following weeks.
Alfonso Moreno
Set and Forget Trading Community
Set and Forget Trading Community
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
Alfonso Moreno
Set and Forget Trading Community
Set and Forget Trading Community
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。